Breakfast matters: new drug tested with high- and Low-Fat meals
NCT ID NCT07348133
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study looked at how eating a high-fat or low-fat breakfast changes the way the body absorbs a new drug called HMPL-523. Eighteen healthy Chinese adults took a single 300 mg tablet under different meal conditions. The goal was to see if food affects drug levels in the blood, which helps guide future dosing instructions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HMPL-523 acetate tablets
- What this could lead to
- If successful, this study will show whether HMPL-523 should be taken with or without food in future trials.
- What could go wrong
- This is a very early, small study in healthy people, not patients. Results may not predict real-world effects or safety in the target disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test